Document Detail


Effects of long-term coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction.
MedLine Citation:
PMID:  2213566     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of coenzyme Q10 (CoQ) and captopril on functional capacity, hemodynamics and survival were studied in 154 rats that recovered after experimental myocardial infarction. Rats were randomized into four groups receiving either CoQ, captopril, a combination of the two drugs or 1 ml of tap water once daily for 12 weeks from the day of coronary artery ligation. CoQ as well as captopril and the combined treatment significantly improved exercise capacity as evaluated by lactate production during a standardized treadmill exercise test. No significant changes in heart rate or mean blood pressure were observed during the study in the captopril-treated group. CoQ treatment increased the maximum heart rate significantly, whereas no effect on mean blood pressure was observed. Both captopril and CoQ decreased pulmonary congestion. Furthermore, the data may suggest that captopril prevents right ventricular hypertrophy seen in placebo-treated rats with large infarcts. This was not observed after CoQ treatment. Captopril treatment improved 3-month probability of survival (93%) as compared with placebo (74%) (P less than .05). CoQ and the combined treatment tended to improve survival, but this was, however, not statistically significant.
Authors:
O M Bech; J D Sørensen; M K Jensen; B Diamant; E Steiness
Related Documents :
2977176 - Atrial natriuretic factor protects the isolated working ischaemic rat heart against the...
18250366 - Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ische...
9861306 - Pulmonary and cardiac expression of preproendothelin-1 mrna are increased in heart fail...
10758976 - Evaluation of the effects of intramyocardial injection of dna expressing vascular endot...
15056836 - Coronary spastic angina in patients with connective tissue disease.
22613516 - First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  255     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1990 Oct 
Date Detail:
Created Date:  1990-11-21     Completed Date:  1990-11-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  346-50     Citation Subset:  IM    
Affiliation:
Department of Clinical Pharmacology, University of Aarhus, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Body Weight / drug effects
Captopril / administration & dosage,  pharmacology*
Coenzymes
Drug Synergism
Energy Metabolism / drug effects
Female
Heart Failure / drug therapy
Hemodynamics / drug effects
Myocardial Infarction / mortality,  physiopathology*
Organ Size / drug effects
Rats
Survival Rate
Ubiquinone / administration & dosage,  blood,  pharmacology*
Chemical
Reg. No./Substance:
0/Coenzymes; 1339-63-5/Ubiquinone; 303-98-0/coenzyme Q10; 62571-86-2/Captopril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A patch clamp study of muscarinic excitation of the rat adrenal chromaffin cells.
Next Document:  Characterization of the effect of two 4-methyl piperidine derivatives of hemicholinium-3, A-4 and A-...